Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Impact of clopidogrel and aspirin treatment on the expression of proteins in platelets from type-2 diabetic patients with stable coronary ischemia.

Azcona L, López Farré AJ, Jiménez Mateos-Cáceres P, Segura A, Rodríguez P, Modrego J, Zamorano-León JJ, Macaya C.

J Pharm Sci. 2012 Aug;101(8):2821-32. doi: 10.1002/jps.23201. Epub 2012 May 21.

PMID:
22614874
3.

Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment.

Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Sabaté M, Jimenez-Quevedo P, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Macaya C.

Diabetes. 2005 Aug;54(8):2430-5.

4.

Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.

Duzenli MA, Ozdemir K, Aygul N, Soylu A, Tokac M.

Am J Cardiol. 2008 Aug 15;102(4):396-400. doi: 10.1016/j.amjcard.2008.03.074. Epub 2008 May 22.

PMID:
18678294
5.

Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.

Verdoia M, Pergolini P, Rolla R, Nardin M, Barbieri L, Schaffer A, Bellomo G, Marino P, Suryapranata H, De Luca G.

Expert Opin Pharmacother. 2015;16(12):1739-47. doi: 10.1517/14656566.2015.1056151. Epub 2015 Jun 12.

PMID:
26067422
6.

Different expression of proteins in platelets from aspirin-resistant and aspirin-sensitive patients.

Mateos-Cáceres PJ, Macaya C, Azcona L, Modrego J, Mahillo E, Bernardo E, Fernandez-Ortiz A, López-Farré AJ.

Thromb Haemost. 2010 Jan;103(1):160-70. doi: 10.1160/TH09-05-0290. Epub 2009 Nov 13.

PMID:
20062920
7.

Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.

Perneby C, Wallén NH, Hofman-Bang C, Tornvall P, Ivert T, Li N, Hjemdahl P.

Thromb Haemost. 2007 Dec;98(6):1316-22.

PMID:
18064330
9.

Impact of pentoxifylline on platelet function profiles in patients with type 2 diabetes mellitus and coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel.

Ueno M, Ferreiro JL, Tomasello SD, Tello-Montoliu A, Capodanno D, Seecheran N, Kodali M, Dharmashankar K, Desai B, Charlton RK, Bass TA, Angiolillo DJ.

JACC Cardiovasc Interv. 2011 Aug;4(8):905-12. doi: 10.1016/j.jcin.2011.05.016.

10.

Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.

Karolczak K, Kamysz W, Karafova A, Drzewoski J, Watala C.

Pharmacol Res. 2013 Aug;74:7-22. doi: 10.1016/j.phrs.2013.04.010. Epub 2013 May 7.

PMID:
23665469
11.

Effect of ASA dose doubling versus switching to clopidogrel on plasma inflammatory markers concentration in patients with type 2 diabetes and high platelet reactivity: the AVOCADO study.

Rosiak M, Postula M, Kaplon-Cieslicka A, Kondracka A, Trzepla E, Czlonkowski A, Janicki PK, Filipiak KJ, Opolski G.

Cardiol J. 2013;20(5):545-51. doi: 10.5603/CJ.2013.0045.

12.

Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease: results of a pharmacodynamic study.

Ueno M, Ferreiro JL, Desai B, Tomasello SD, Tello-Montoliu A, Capodanno D, Capranzano P, Kodali M, Dharmashankar K, Charlton RK, Bass TA, Angiolillo DJ.

JACC Cardiovasc Interv. 2012 Mar;5(3):293-300. doi: 10.1016/j.jcin.2011.09.027.

13.

Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.

Tetik S, Ak K, Isbir S, Eksioglu-Demiralp E, Arsan S, Iqbal O, Yardimci T.

Clin Appl Thromb Hemost. 2010 Apr;16(2):189-98. doi: 10.1177/1076029609344980. Epub 2009 Aug 23.

PMID:
19703819
14.

Postmenopausal women have an increased maximal platelet reactivity compared to men despite dual antiplatelet therapy.

Bobbert P, Stellbaum C, Steffens D, Schütte C, Bobbert T, Schultheiss HP, Rauch U.

Blood Coagul Fibrinolysis. 2012 Dec;23(8):723-8. doi: 10.1097/MBC.0b013e32835824b3.

PMID:
23135379
15.

Normalization of platelet reactivity in clopidogrel-treated subjects.

Vilahur G, Choi BG, Zafar MU, Viles-Gonzalez JF, Vorchheimer DA, Fuster V, Badimon JJ.

J Thromb Haemost. 2007 Jan;5(1):82-90.

16.

Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination.

Cooke GE, Liu-Stratton Y, Ferketich AK, Moeschberger ML, Frid DJ, Magorien RD, Bray PF, Binkley PF, Goldschmidt-Clermont PJ.

J Am Coll Cardiol. 2006 Feb 7;47(3):541-6. Epub 2006 Jan 18.

17.
18.

Aspirin and clopidogrel treatment impair nitric oxide biosynthesis by platelets.

O'Kane PD, Reebye V, Ji Y, Stratton P, Jackson G, Ferro A.

J Mol Cell Cardiol. 2008 Aug;45(2):223-9. doi: 10.1016/j.yjmcc.2008.05.015. Epub 2008 Jul 7.

PMID:
18606420
19.

Effects of combined therapy with clopidogrel and acetylsalicylic acid on platelet glycoprotein expression and aggregation.

Dörr G, Schmidt G, Gräfe M, Regitz-Zagrosek V, Fleck E.

J Cardiovasc Pharmacol. 2002 Apr;39(4):523-32.

PMID:
11904526
20.

Effect of combined administration of clopidogrel and lysine acetylsalicylate versus clopidogrel and aspirin on platelet aggregation and activated GPIIb/IIIa expression in healthy volunteers.

Majluf-Cruz A, Chavez-Ochoa AR, Majluf-Cruz K, Coria-Ramirez E, Pineda Del Aguila I, Treviño-Perez S, Matías-Aguilar L, López-Armenta JC, Corona de la Peña N.

Platelets. 2006 Mar;17(2):105-7.

PMID:
16421012

Supplemental Content

Support Center